ArticleExperimental and therapeutic medicine2022

Prevention of acute graft-vs.-host disease by targeting glycolysis and mTOR pathways in activated T cells.

Rui-Qing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.